Results 1 - 10 of 2238

< 1 2 3 ... 223 224 >

• Wanke Riccardo, Novais David A., Harjivan Shrika G., Marques M. Matilde, Antunes Alexandra M. M.. Biomimetic oxidation of aromatic xenobiotics: synthesis of the phenolic metabolites from the anti-HIV drug efavirenz, Organic & Biomolecular Chemistry, 2012

  [PubMed: 22569890]
  [DOI: 10.1039/C2OB25212K]
  
• Jones LH; Allan G; Barba O; Ringrose H; Swain NA; Webster R; Westby M; Phillips C; Burt C; Corbau R; Dupont T; Kn?chel T; Irving S; Middleton DS; Mowbray CE; Perros M. Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays., Journal of medicinal chemistry

  [PubMed: 19175319]
  [DOI: 10.1021/jm801322h]
  
• Naidoo A; Chirehwa M; McIlleron H; Naidoo K; Essack S; Yende-Zuma N; Kimba-Phongi E; Adamson J; Govender K; Padayatchi N; Denti P. Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB., The Journal of antimicrobial chemotherapy

  [PubMed: 28175315]
  [DOI: 10.1093/jac/dkx004]
  
• Zhang L; Li L; Shi W; Zhuo L; Wang X; Liu S; Liang X; Ye Z; Wang WJ; Zhang B; Li R; Chen Y; Yu C. Pharmacokinetics of moxifloxacin in critically ill patients with impaired renal function undergoing pulse high-volume haemofiltration., International journal of antimicrobial agents

  [PubMed: 23876335]
  [DOI: 10.1016/j.ijantimicag.2013.06.]
  
• Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study., Clinical therapeutics

  [PubMed: 18343264]
  [DOI: 10.1016/j.clinthera.2008.02.00]
  
• Soorju V; Naidoo P. Confirmation of factors that influence antiretroviral regimen change and the subsequent patient outcomes at a Regional Hospital in rural KwaZulu-Natal., African journal of primary health care & family medicine

  [PubMed: 28155312]
  
• Calza L; Magistrelli E; Danese I; Colangeli V; Borderi M; Bon I; Re MC; Mancini R; Conti M; Motta R; Viale P. Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz., Current HIV research

  [PubMed: 26531764]
  
• Shafer RW. Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update., The Journal of infectious diseases

  [PubMed: 28968669]
  [DOI: 10.1093/infdis/jix398]
  
• de Moraes Filho AV; de Jesus Silva Carvalho C; Ver?osa CJ; Gon?alves MW; Rohde C; de Melo E Silva D; Cunha KS; Chen-Chen L. In vivo genotoxicity evaluation of efavirenz (EFV) and tenofovir disoproxil fumarate (TDF) alone and in their clinical combinations in Drosophila melanogaster., Mutation research

  [PubMed: 28676264]
  [DOI: 10.1016/j.mrgentox.2017.05.012]
  
• Avihingsanon A; Maek-A-Nantawat W; Gatechompol S; Sapsirisavat V; Thiansanguankul W; Sophonphan J; Thammajaruk N; Ubolyam S; Burger DM; Ruxrungtham K. Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-na?ve and experienced HIV-1-infected Thai adults., International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

  [PubMed: 28627427]
  [DOI: 10.1016/j.ijid.2017.06.009]